- Home
- MCW vs DNLI Comparison
MCW vs DNLI Comparison
Compare MCW & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCW
- DNLI
- Stock Information
- Founded
- MCW 1996
- DNLI 2013
- Country
- MCW United States
- DNLI United States
- Employees
- MCW N/A
- DNLI N/A
- Industry
- MCW
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MCW
- DNLI Health Care
- Exchange
- MCW Nasdaq
- DNLI Nasdaq
- Market Cap
- MCW 2.2B
- DNLI 2.1B
- IPO Year
- MCW 2021
- DNLI 2017
- Fundamental
- Price
- MCW $6.70
- DNLI $14.47
- Analyst Decision
- MCW Hold
- DNLI Strong Buy
- Analyst Count
- MCW 6
- DNLI 15
- Target Price
- MCW $8.29
- DNLI $33.85
- AVG Volume (30 Days)
- MCW 1.7M
- DNLI 1.5M
- Earning Date
- MCW 07-30-2025
- DNLI 08-04-2025
- Dividend Yield
- MCW N/A
- DNLI N/A
- EPS Growth
- MCW 4.42
- DNLI N/A
- EPS
- MCW 0.24
- DNLI N/A
- Revenue
- MCW $1,017,200,000.00
- DNLI N/A
- Revenue This Year
- MCW $7.57
- DNLI N/A
- Revenue Next Year
- MCW $7.57
- DNLI $323.34
- P/E Ratio
- MCW $27.90
- DNLI N/A
- Revenue Growth
- MCW 8.18
- DNLI N/A
- 52 Week Low
- MCW $5.84
- DNLI $10.57
- 52 Week High
- MCW $8.60
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- MCW 55.70
- DNLI 51.07
- Support Level
- MCW $6.30
- DNLI $13.70
- Resistance Level
- MCW $6.56
- DNLI $15.15
- Average True Range (ATR)
- MCW 0.20
- DNLI 0.65
- MACD
- MCW 0.04
- DNLI -0.06
- Stochastic Oscillator
- MCW 75.38
- DNLI 45.97
About MCW Mister Car Wash Inc.
Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.